Status:
SUSPENDED
A Study to Evaluate Continuous Glucose Monitor in Hospitalized, Post-operative Patients With Diabetes Mellitus
Lead Sponsor:
Mayo Clinic
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purposes of this study is to study if CGMs worn in the postoperative ICU or non-ICU hospital setting have adequate accuracy for blood glucose monitoring when compared to point-of-care (POC) capill...
Detailed Description
Eligible patients will be approached by research staff either preoperatively or on the first 5 days post-surgery and offered to be enrolled. If agreed to participate, they will be fitted with a blinde...
Eligibility Criteria
Inclusion
- Patients with Type 1 or 2 Diabetes Mellitus.
- Patients 18 years of age or older.
- Admitted for deceased donor renal transplant surgery, pancreas transplant surgery, heart transplant surgery, liver transplant surgery and lung transplant surgery.
- Anticipated minimum of 72h hospital stay.
- Patients on insulin therapy (IV, SQ) post-surgery.
Exclusion
- Active COVID-19 infection.
- Pregnant or lactating female.
- Altered Mental Status at the time of sensor placement (sensor will be placed once mental status will improve).
- Inability to provide informed consent.
- Patients taking more than 4 g of acetaminophen in 24 hours or more than 1 gm every 6 hours.
- Patients with skin lesions at the application site that may interfere with placement of the sensor.
- Patients with known allergy to medical grade adhesive.
Key Trial Info
Start Date :
June 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 8 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04845685
Start Date
June 1 2026
End Date
December 8 2026
Last Update
July 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224